Regulation of Forkhead Transcription Factor FoxO3a Contributes to Calorie Restriction-induced Prevention of Alzheimer's Disease-type Amyloid Neuropathology and Spatial Memory Deterioration

• Published in: Annals of the New York Academy of Sciences 2008-12, Vol.1147 (1), p.335-347
• Main Authors: Qin, Weiping, Zhao, Wei, Ho, Lap, Wang, Jun, Walsh, Kenneth, Gandy, Sam, Pasinetti, Giulio Maria
• Format: Article
• Language: English
• Subjects: Alzheimer Disease; Alzheimer's disease; Amyloid - metabolism; amyloid-β peptide; Animals; Blotting, Western; Brain - metabolism; Caenorhabditis elegans; Caloric Restriction; calorie restriction; Cricetinae; Enzyme-Linked Immunosorbent Assay; Female; Forkhead Box Protein O3; Forkhead transcription factor FoxO3a; Forkhead Transcription Factors - physiology; Immunohistochemistry; Insulin - metabolism; Memory Disorders; Mice; Mice, Transgenic; Phosphorylation; Signal Transduction
• ISSN: 0077-8923; 1749-6632; 1930-6547
• DOI: 10.1196/annals.1427.024

Forkhead transcription factor FoxO3a, also known as DAF‐16 in Caenorhabditis elegans, is a key regulator of the insulin receptor (IR)/insulin‐like growth factor‐I signaling pathway mediated extension of life span in worms and yeast. In this study, we report that calorie restriction (CR)‐mediated activation of the IR signaling pathway leads to hyperphosphorylation of FoxO3a transcription factor and, consequently, its exclusion from the nucleus. This inactivation of FoxO3a activity is correlated with attenuation of Alzheimer's disease (AD)‐type amyloid neuropathology and with preservation of spatial reference memory in the Tg2576 mouse model of AD. Further, in vitro studies reveal that exogenous expression of viral, triple‐mutant, constitutively active FoxO3a resulting in increased nuclear FoxO3a activity in primary neuron cultures derived from Tg2576 mouse embryos, causally promotes AD amyloid‐β peptide (Aβ) levels by inhibiting nonamyloidogenic α‐secretase activity, indicating the existence of an inverse correlation between FoxO3a activity and cerebral Aβ amyloidosis. Moreover, we report for the first time that the exclusion of the FoxO3a transcription factor from the nucleus in combination with inhibition of nuclear FoxO3a activity by SIRT1‐mediated deacetylation in response to CR is a mechanism resulting in the repression of Rho‐associated protein kinase‐1 gene expression, thereby activating nonamyloidogenic α‐secretase processing of the amyloid precursor protein and lowering Aβ generation. This study provides a novel metabolic pathway for prevention and/or treatment of AD.